Literature DB >> 3566060

Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla.

G S Giebink, M L Ripley, P F Wright.   

Abstract

The eustachian tubes of 29 influenza A virus-infected chinchillas were examined for histopathologic signs at intervals up to 21 days after inoculation to elucidate the pathologic basis of negative middle ear pressure, which occurs during viral respiratory tract infection in humans. In the animal model, eardrum inflammation and negative middle ear pressure mirrored epithelial damage in the eustachian tube and the accumulation of cellular and mucous debris in the tubal lumen. Epithelial damage was greatest in the proximal two thirds of the tube near the nasopharynx, whereas goblet cell metaplasia and increased secretory activity was greatest in the distal, tympanic one third of the tube. These results provide a morphologic correlate to the development of negative middle ear pressure, and perhaps explain the pathologic basis for purulent otitis media during viral respiratory tract infection.

Entities:  

Mesh:

Year:  1987        PMID: 3566060     DOI: 10.1177/000348948709600212

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  22 in total

1.  Influenza virus induces bacterial and nonbacterial otitis media.

Authors:  Kirsty R Short; Dimitri A Diavatopoulos; Ruth Thornton; John Pedersen; Richard A Strugnell; Andrew K Wise; Patrick C Reading; Odilia L Wijburg
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.

Authors:  Glen McGillivary; William C Ray; Charles L Bevins; Robert S Munson; Lauren O Bakaletz
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

Review 3.  Secondary bacterial infections in influenza virus infection pathogenesis.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

4.  Mapping the anatomy of respiratory syncytial virus infection of the upper airways in chinchillas (Chinchilla lanigera).

Authors:  Jessica L Grieves; Joseph A Jurcisek; Brian Quist; Russell K Durbin; Mark E Peeples; Joan E Durbin; Lauren O Bakaletz
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

5.  Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media.

Authors:  K Suzuki; L O Bakaletz
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Rhinovirus disrupts the barrier function of polarized airway epithelial cells.

Authors:  Umadevi Sajjan; Qiong Wang; Ying Zhao; Dieter C Gruenert; Marc B Hershenson
Journal:  Am J Respir Crit Care Med       Date:  2008-09-11       Impact factor: 21.405

7.  Influenza A modification of endotoxin-induced otitis media with effusion in the guinea pig.

Authors:  Y Ohashi; Y Nakai; Y Ohno; Y Sugiura; H Okamoto; H Sakamoto; M Hayashi
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

8.  Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.

Authors:  H H Tong; J P Long; P A Shannon; T F DeMaria
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

Review 10.  Immunopathogenesis of polymicrobial otitis media.

Authors:  Lauren O Bakaletz
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.